Gilead Sciences Canada Inc.

---

Registration: 6 of 6 (2024-08-14 to present)

Details Regarding the Identified Subject Matter

Subject matters	Details	Categories
Health, Industry, Research and Development	Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines	Policies or Program
Aboriginal Affairs, Health	Federal Government First Nations and Inuit Health Branch program with respect to health services.	Policies or Program
Health	Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.	Policies or Program
Health, Industry, Research and Development	Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector	Policies or Program
Health, Industry	o Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.	Legislative Proposal, Bill or Resolution
Health	Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.	Policies or Program